)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Microbix Biosystems
Microbix Biosystems (MBX) investor relations material
Microbix Biosystems Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary12 Feb, 2026
Executive summary
Q1 2026 revenue was CAD 4.2 million, up 13% sequentially but down 30% year-over-year, reflecting recovery after setbacks with two major clients in 2025.
Net loss for the quarter was CAD 1.2 million, managed using cash reserves, compared to net income of CAD 857,000 in Q1 2025.
Strategic focus remains on expanding sales to test makers, PT/EQA providers, and clinical labs, with a growing, more diversified client base.
New client relationships and product launches, including recombinant SARS-CoV-2 antigen, are supporting growth.
The Kinlytic urokinase drug program is advancing, with milestone payments received and further FDA filings planned.
Financial highlights
Q1 2026 revenue: CAD 4,218,909, a 13% increase from the previous quarter but down 30% year-over-year due to a sharp drop in China distributor sales.
Gross margin was 41%, below expectations and down from 62% in Q1 2025, impacted by lower sales volume and fixed overhead absorption.
Operating and net loss: CAD 1,167,177 (vs. operating and net income of CAD 856,962 in Q1 2025).
Cash balance at end of January was CAD 10.6 million, up CAD 1.5 million from December, with strong liquidity and C$9.1 million at quarter-end.
Accounts receivable increased to CAD 3,984,395 from CAD 1,610,509 at prior year-end, attributed to timing of shipments; most have since been collected.
Outlook and guidance
Annual revenue is targeted at CAD 18.5–19 million, about 30% above the 2025 low point, with double-digit annual sales growth targeted beyond 2026.
Profitability is expected to be reached or closely approached in Q4 2026, contingent on order timing and new business wins, but further net losses are anticipated in the next two quarters.
No significant seasonality expected in revenue or OpEx trends.
Kinlytic re-launch: key milestones and financial impact
QAPS growth strategy: PoCT, new sectors, and regulatory impact
Path to breakeven: address Q1 revenue decline and cash usage
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Microbix Biosystems earnings date
Q2 202614 May, 2026
Microbix Biosystems
Next Microbix Biosystems earnings date
Q2 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Microbix Biosystems Inc. is a life sciences company that develops and commercializes a range of proprietary biological and technological solutions aimed at improving human health and wellbeing. The company, established in 1988, has a focus on the global diagnostics industry, producing high-quality biological materials. These include antigens used in immunoassays and various Quality Assessment and Proficiency (QAPs) testing products. Microbix Biosystems also manufactures diagnostic-test products, including test-controls under the QAPs brand and viral transport mediums used for collecting patient samples. Additionally, the company is involved in the development of Kinlytic, a biologic thrombolytic drug for treating blood clots. The company is headquartered in Mississauga, Ontario, Canada, and its shares are listed on the Toronto Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage